The American College of Neuropsychopharmacology (ACNP) is the nation's premier professional society in brain, behavior, and psychopharmacology research.
Check out our new Deep Dive on the recent ACNP @ACNPorg position paper that lays out actionable strategies to advance biomarker-enabled precision psychiatry and improve coordination across scientific, regulatory, clinical, and commercial stakeholders.
https://t.co/9Ffxfob8tF
Apply Today! Now accepting Early-Stage Investigator Assistance Program & Associate Member Assistance Program applications for the ACNP 65th Annual Meeting, Jan. 10-13, 2027, San Diego, CA. Deadline: Oct. 30, 2026, at 5 pm CST. For more info, visit: https://t.co/O7vpCa7e1a
The deadline is quickly approaching! ACNP Promising Targets Submissions are open for the ACNP 65th Annual Meeting, January 10-13, 2027, in San Diego, California. 😎 Deadline to Submit is October 28 at 5:00pm Central. For more information, visit: https://t.co/laV9E3TYp2
ACNP Promising Targets Submissions are OPEN for the ACNP 65th Annual Meeting, January 10-13, 2027, in San Diego, California. 🎉 Deadline to submit is October 28th at 5:00 pm Central. For more information, visit: https://t.co/laV9E3TYp2
ACNP is now accepting Early-Stage Investigator Assistance Program & Associate Member Assistance Program applications for the 65th Annual Meeting, Jan. 10-13, 2027, San Diego, CA. Deadline to submit: October 30, 2026, at 5:00 pm CST. For more info, visit: https://t.co/O7vpCa7e1a
🚀 Introducing Unconventional Journeys, a new video series exploring the real, often non-linear paths people take into brain research. Supported by the American College of Neuropsychopharmacology (ACNP).
In the first episode, Dr Leah Mayo shares candid insights on navigating early career doubts, meeting the right people at the right time, and how those experiences shaped her work in translational research and neuropharmacology.
🎬 Watch the 4-minute episode using the link below if you’ve ever felt your own path doesn’t look the way its “supposed” to:
https://t.co/oHU2sMaIiO
@FENSorg@SfNtweets@IBROorg@ACNPorg
BREAKING NEWS
The 2026 #NobelPrize in Physiology or Medicine has been awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel “for their discoveries concerning light-gated ion channels and optogenetics.”
Congratulations to ACNP member Karl Deisseroth, MD, PhD (@Stanford) on the 2026 #NobelPrize in Physiology or Medicine! He shares the honor with Peter Hegemann and Georg Nagel for discoveries in light-gated ion channels and #optogenetics. A proud day for our field. 🧠💡
Last chance! The deadline to apply to become a member of the American College of Neuropsychopharmacology is TODAY, September 24th at 5:00 pm Central. 🤩 Click ➡️ https://t.co/w1PYm1SNfQ for more information.
Clinical trials in psychiatry rely on measures of symptomatology, not biology.
This @ACNPorg position paper lays out why validated biomarkers in psychiatry have lagged behind fields like Alzheimer's and ALS, and what it will take to close the gap: precompetitive data sharing, standardized protocols, & earlier FDA engagement.
https://t.co/llfVyU9w4r
ACNP and Neuropsychopharmacology are proud to announce our new partnership with Elsevier starting January 2027 - Click Here to Read More ➡️ https://t.co/4ioltbFrIv
ABC Congressional Neuroscience Caucus Briefing: Psychedelics in Brain Health - Keynote: Jaclyn “Jax” Scott, - Moderator: Mark M. Rasenick, PhD, Panel of Experts: Tiffany Farchione, MD, FAPA, Harriet de Wit, PhD, Ivan Montoya, MD, MPH, Daniel Karlin, MD, MA, Steve Levine, MD 🧠